Hormonal changes in Polycystic ovary disease is:
**Core Concept**
Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder characterized by hormonal imbalance, ovulatory dysfunction, and hyperandrogenism. The underlying pathophysiology involves insulin resistance, increased androgen production, and abnormal gonadotropin secretion.
**Why the Correct Answer is Right**
The hormonal changes in PCOS are primarily driven by insulin resistance, which leads to increased production of androgens by the ovaries and adrenal glands. This is mediated by the enzyme 17α-hydroxylase, which is involved in the biosynthesis of androgens from cholesterol. Additionally, PCOS is associated with hypersecretion of luteinizing hormone (LH) and decreased secretion of follicle-stimulating hormone (FSH), leading to anovulation and cyst formation on the ovaries.
**Why Each Wrong Option is Incorrect**
**Option A:** This option does not provide any specific information about hormonal changes in PCOS.
**Option B:** This option is incorrect as it does not accurately describe the hormonal changes in PCOS.
**Option C:** This option is incorrect as it is not directly related to the hormonal changes in PCOS.
**Clinical Pearl / High-Yield Fact**
Insulin-sensitizing agents such as metformin can improve insulin sensitivity and reduce androgen production in women with PCOS, making them a valuable adjunctive treatment option.
**Correct Answer: C. Hypersecretion of luteinizing hormone (LH) and decreased secretion of follicle-stimulating hormone (FSH).**